Skip to main content
SpringerLink
Log in
Book cover

Koronarerkrankungen pp 1161–1183Cite as

Antikoagulation, Aggregationshemmer, Fibrinolyse

  • Chapter

  • 39 Accesses

Part of the book series: Handbuch der inneren Medizin ((INNEREN 9,volume 9 / 3))

Zusammenfassung

Pathologisch-anatomisches Substrat der Therapie mit gerinnungsbeeinflussenden Medikamenten ist das Blutgerinnsel. Durch Fibrinolytika soll das Fibringerinnsel wieder aufgelöst werden, Antikoagulantien sollen seine Bildung verhindern und die Aggregationshemmer durch eine Änderung der Thrombozyteneigenschaften eventuell auch die Progression der koronaren Herzkrankheit beeinflussen.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aber CP, Bass NM, Berry CL, Carson PHM, Dobbs RJ, Fox KM, Hamblin JJ, Haydn SP, Howitt G, Macver JE, Portal RW, Raftery GB, Roussell RH, Stock JPP (1976) Streptokinase in acute myocardial infarction: A controlled multicentre study in the United Kingdom. Br Med J 2: 1100–1104

    Google Scholar 

  • Anschüz F, Hensel W-H (1973) Antikoagulantien nach Myokardinfarkt: Durchführung und Beurteilung der Dauertherapie. Diagnostik 6: 231–233

    Google Scholar 

  • Anturane Reinfarction Trial Research Group (1980) Sulfinpyrazone in the prevention of sudden death after myocardial infarction. N Engl J Med 302: 250–256

    Article  Google Scholar 

  • Anturane Reinfarction Italian Study Group (1982) Sulfinpyrazon in post-myocardial infarction. Lancet 1982 /1: 237–242

    Google Scholar 

  • Aspirin Myocardial Infarction Study Research Group (1980) A randomized controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 243: 661–669

    Article  Google Scholar 

  • Beck OA, Nunberger D, Hochrein H (1978) Initiale Heparintherapie und orale Antikoagulantien beim akuten Myokardinfarkt. Med Welt 29: 232–236

    PubMed  CAS  Google Scholar 

  • Bell WR, Royall RM (1980) Heparin-associated thrombozytopenia: A comparison of three heparin preparations. N Engl J Med 303: 902–907

    Google Scholar 

  • Benda L, Haider M, Ambrosch F (1977) Ergebnisse der österreichischen Herzinfarktstudie mit Streptokinase. Wien Klin Wochenschr 89: 779–783

    PubMed  CAS  Google Scholar 

  • Bett JHN (1977) Australian multicentre trial of streptokinase in acute myocardial infarction. Med J Austr 1: 553–555

    Google Scholar 

  • Chalmers ThC, Matta RJ, Smith H, Kunzler A-U (1977) Evidence favouring the use of anticoagulants in the hospital phase of acute myocardial infarction. N Engl J Med 297: 1091–1096

    Article  PubMed  CAS  Google Scholar 

  • Connfleld J(1951)A method of estimating comparative rates from clinical data: Applica-tions to cancer of the lung, brest and cervix: J Natl Cancer Inst 2:1269–1271

    Google Scholar 

  • Cooperative Clinical Trial Group (1973) Anticoagulants in acute myocardial infarction. Results of a cooperative clinical trial. JAMA 225: 724–729

    Article  Google Scholar 

  • Coronary Drug Project Research Group (1976) Aspirin in the coronary heart disease. J Chronic Dis 29: 625–642

    Article  Google Scholar 

  • Craven LL (1953) Experiences with aspirin (acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis. Mississippi Valley Med J 75: 38–44

    CAS  Google Scholar 

  • Curtin T, Mulhern B (1980) Foetal warfarin syndrome. Ir Med J 73: 393–394

    PubMed  CAS  Google Scholar 

  • Deutsch E (1977) Die Stellung der gerinnungshemmenden Therapie in der Behandlung des Myokardinfarktes. In: Schettler G, Horsch A, Morl H, Orth H, Weizel A (Hrsg) Der Herzinfarkt. Schattauer, Stuttgart New York, S 379–389

    Google Scholar 

  • Dioguardi N, Lotto A, Levi GF, Rota M, Proto C, Mannucci PM, Rossi P, Lomanto B, Mattei G, Fiorelli G, Agostini A (1971) Controlled trial of streptokinase and heparin in acute myocardial infarction. Lancet 1971 /2: 891–895

    Article  Google Scholar 

  • Douglas AG, McNicol GP (1976) In: Biggs R (ed) Human blood coagulation, haemostasis and thrombosis. Blackwell, pp 557–564

    Google Scholar 

  • Drapkin A, Merskey L (1972) Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient’s age, sex, and severity of infarction. J Am Med Ass 222: 541–542

    Google Scholar 

  • Dukert F, Market GA (1977) Die Kontrolle der oralen Antikoagulantien: der therapeutische Bereich. Rundschau Med (Praxis) 66: 293–294

    Google Scholar 

  • Elwood PC, Sweetnam PM (1979) Aspirin and secondary mortality after myocardial infarction. Lancet 11: 1313–1315

    Article  Google Scholar 

  • Elwood PC, Williams WO (1979) A randomized controlled trial of aspirin in the prevention of early mortality in myocardial infarction. J R Col Gen Pract 29: 413–416

    CAS  Google Scholar 

  • Elwood PC, Cochrane AL, Burr ML, Sweetnam PM, Wilhams G, Welsby L, Hughes SI, Renton R (1974) A randomized trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J 1: 436–440

    Article  PubMed  CAS  Google Scholar 

  • Emerson PA (1978) Preventing thromboembolism after myocardial infarction: Effect of low-dose heparin or smoking. Am Heart J 96: 129

    Article  PubMed  CAS  Google Scholar 

  • EPSIM Research Group (1982) A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction. N Engl J Med 307: 701–708

    Article  Google Scholar 

  • European Collaborative Study Group (1975) Controlled trial of urokinase in acute myocardial infarction. A european collaborative study. Lancet II: 624–626

    Google Scholar 

  • European Cooperative Study Group (1979) Streptokinase in acute myocardial infarction. N Engl J Med 15: 797–802

    Google Scholar 

  • FDA Drug Bulletin (1978) Sulfinpyrazone and prevention of myocardial infarction. May/ July 1978, pp 19–20

    Google Scholar 

  • Fletcher AP, Sherry S, Alkjeaersis N, Smyrniotis FE, Jick S (1959) The maintainance of sustained thrombolytic state in man (II). Clinical observation on patients with myocardial infarction and other thromboembolic disorders. J Clin Invest 38: 1111–1119

    Google Scholar 

  • Forfar JC (1979) A 7-year analysis of haemorrhase in patients on long-term anticoagulant treatment. Br Heart J 42: 128–132

    Article  PubMed  CAS  Google Scholar 

  • Fulton RM, Duckett K (1976) Plasma-fibrinogen and thromboemboli after myocardial infarction. Lancet II: 1161–1164

    Google Scholar 

  • Gallus AG, Hirsch J, Tutle RJ, Trebilcock R, O’Brien GE, Carroll JJ, Minden JH, Hudecki SM (1973) Small subcutaneous doses of heparin in prevention of venous thrombosis. N Engl J Med 288: 545–551

    Article  PubMed  CAS  Google Scholar 

  • Genton E (1980) A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease. Circulation [Suppl V] 62: 111–121

    Google Scholar 

  • Goldman L, Feinstein AR (1979) Anticoagulants and myocardial infarction. The problem of pooling, drowing and floaring. Ann Intern Med 90: 92–94

    Google Scholar 

  • Griffith EH, Hero N (1979) Chronic use of anticoagulants, psychosocial adaptation. NY State J Med pp 90–92

    Google Scholar 

  • Handley AJ (1972) Heparin in the prevention of deep vein thrombosis after myocardial infarction. Br Med J II: 436–438

    Google Scholar 

  • Heene DL (1980) Cumarin-Derivate: Ärztliche Überwachung. Aus: Kontrolle von An- tithrombotika. In: Marx R, Thies HA (Hrsg) XXIII Hamburger Symposium über Blutgerinnung. Editiones Roche, S 131–135

    Google Scholar 

  • Heene DL, Schöndorf Th, Matthias FR (1977) Antikoagulantienanwendung in der Inneren Medizin. Klinische Indikationen, Kontraindikationen und Ergebnisse. In: Marx R, Thiess HA (Hrsg) Klinische und ambulante Anwendung klassischer Antikoagulantien. Schattauer, Stuttgart New York, S 91–111

    Google Scholar 

  • Hilden T, Iversen L, Raaschou F, Schwartz M (1961) Anticoagulants in acute myocardial infarction. Lancet 1: 327–330

    Article  Google Scholar 

  • Hoppe J, Maaß H (1982) Hepatitisrisiko von konventionellen PPS B-Poolpräparaten. Dtsch Med Wochenschr 107: 1966–1968

    Article  PubMed  CAS  Google Scholar 

  • Hurst JW, Logue RB, Walter PF (1978) The clinical recognition and medical management of coronary atherosclerotic heart disease. In: Hurst JW (ed) The Heart. 4th edn. McGraw Hill, New York, pp 1156–1291

    Google Scholar 

  • International Anticoagulant Review Group (1970) Collaborative analysis of long term anticoagulant administration after acute myocardial infarction. Lancet 1: 203–209

    Google Scholar 

  • Link KP (1959) The discovery of dicumarol adits sequels. Circulation 19: 97–107

    PubMed  CAS  Google Scholar 

  • Linos A, Worthington JW, O’Fallon W, Fuster V, Whisnant JP, Kurland LT (1978) Effect of aspirin on prevention of coronary and cerebrovascular disease in patients with rheumatoid arthritis. A long-term follow-up study. Mayo Clin Proc 53: 581–584

    Google Scholar 

  • Loeliger EA (1961) Der holländische Thrombosedienst. Wien Klin Wochenschr 51: 915–923

    Google Scholar 

  • Loeliger EA (1983) Oral anticoagulants and/or aspirin. In: Roskamm H (ed) Prognosis of coronary heart disease - progression of coronary arteriosclerosis. Springer, Berlin Heidelberg New York, p 223

    Chapter  Google Scholar 

  • Madhock RK, Sharma SK (1978) Rheologische Veränderungen des Blutes beim akuten Myokardinfarkt. Schwerpunkt Med 2: 93–95

    Google Scholar 

  • Mallory TB (1939) Am Heart J 17: 667

    Google Scholar 

  • Mannucci PM (1972) Streptokinase in recent myocardial infarction: Short and long-term evaluation. Abstractbook, III Congress of the International Society of Thrombosis and Haemostasis, Washington DC, p 434

    Google Scholar 

  • Maunt MJ, Thong KL, Birthwhistle RV, Brain BD, Hammond GW, Grace MG (1977) Haemorrhagic complications of heparintherapy. Lancet 1977 /1: 1133–1135

    Article  Google Scholar 

  • May GS, Eberlein KA, Furberg CD, Passamani ER, DeMets DL (1982) Secondary prevention after myocardial infarction: A review of long-term trials. Progr Cardiovsc Dis 24: 331–352

    Article  CAS  Google Scholar 

  • Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y, Thompson SG (1980) Haemostatic function and cardiovascular death: Early results of a prospective study. Lancet 1: 1050–1053

    Google Scholar 

  • Meyer J, Merx W, Schweizer P, Erbel R, Schmitz HJ, Dörr R, Messmer BJ, Effert S (1982) Ballondilatation und Operation als Anschlußmaßnahme nach erfolgreicher Thrombolyse. Z Kardiol 71: 591 (abstr)

    Google Scholar 

  • Nicolaides AN, Kakkar VY, Renney JTG, Kidner PH, Hutchinson PCS, Clarke MB (1971) Myocardial infarction and deep-vein thrombosis. Br Med J 1971 /1: 432–436

    Article  Google Scholar 

  • O’Grady J, Moucada S (1959) Aspirin: A paradoxical effect on bleeding time. Lancet 11: 780

    Google Scholar 

  • Owren PA (1959) Thrombotest: A new method for controlling anticoagulant-therapy. Lancet 1959 /2: 754–755

    Article  Google Scholar 

  • Packham MA, Mustard JF (1980) Pharmacology of platelet affecting drugs. Circulation 62 [Suppl V]: 26–41

    Google Scholar 

  • Passamani ER (1980) Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease. Circulation 62 [Suppl V]: 106–110

    Google Scholar 

  • Quick AJ (1935) The prothrombin in haemophilia and in obstructive jaundice. J Biol Chem 73: 109–111

    Google Scholar 

  • Rentrop P, Blanke H, Karsch KR, Kaiser H, Köstering H, Leitz K (1981) Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 63: 307–317

    Article  PubMed  CAS  Google Scholar 

  • Ritter B, Schöll V, Gohlke H, Betz P, Budde U, Roskamm H (1982) Normalisierung des belastungsinduzierten Anstiegs von Plättchenfaktor 4 bei Patienten mit Herzinfarkt unter 40 Jahren. Verh Dtsch Ges Inn Med 88: 1153–1156

    Google Scholar 

  • Roberts WC, Ferrans VJ (1976) The role of thrombosis in the etiology of atherosclerosis (a positive one) and in precipitating fatal ischemic heart disease (a negative one). In: Donoso E, Haft JI (eds) Current cardiovascular topics II: Thrombosis, platelets, anticoagulation and acetylsalicylic acid. Thieme, Stuttgart, pp 143–155

    Google Scholar 

  • Roskamm H, Gohlke H, Stürzenhofecker P, Droste C, Thomas H, Samek L, Schnellbacher K, Betz P (1983) Der Herzinfarkt im jugendlichen Alter (unter 40 Jahren): Koronarmorphologie, Risikofaktoren, Langzeitprognose der Erkrankung und Progression der Koronargefäßsklerose. Z Kardiol 72: 1–11

    Google Scholar 

  • Russo JV, Margolis S, Friesinger GC, Ross RS (1970) Heparin and ventricular arrhythmias after myocardial infarction. Lancet II: 1271–1275

    Article  Google Scholar 

  • Salzmann EW, Deykin D, Shapiro RM, Rosenberg R (1975) Management of heparin therapy: Controlled prospective trial. N Engl J Med 292: 1046–1050

    Article  Google Scholar 

  • Schmutzler R, Heckner F, Körtge P, van de Loo J, Petzold FA, Pretorius F, Polivoda H, Zekorn D (1966) Zur fibrinolytischen Therapie des frischen Herzinfarktes. Dtsch Med Wochenschr 91: 581–585

    CAS  Google Scholar 

  • Schmutzler R, Fritze E, Gebauer D, Gillmann H, Heckner F, Körtge P, van de Loo J, Petzold FA, Polivoda H, Prätorius F, Zekorn D (1971) Fibrinolytic therapy in acute myocardial infarction. Thrombos Diathesis Haemorrh 47 [Suppl]: 211–215

    Google Scholar 

  • Schröder R, Biamino G, Leitner ER v, Linderer Th, Hertz J, Vöhringer HF, Wegscheider K, Andresen D, Arntz HR, Brüggemann Th, Grassot A, Lichey J, Oeff M, Prokein E, Schäfer JH, Sörensen R (1982) Systemische Thrombolyse mit Streptokinase-Kurz- infusion beim akuten Myokardinfarkt. Z Kardiol 71: 703–718

    Google Scholar 

  • Selzer A (1978) Use of anticoagulant agents in acute myocardial infarction: Statistics or clinical judgement? Am J Cardiol 41: 1315–1317

    Article  PubMed  CAS  Google Scholar 

  • Silvoso GR, Ivey KJ, Butt JH, Lockard OO, Holt SD, Sisk C, Baskin WN, Mackerchier PA, Hewett J (1979) Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 91: 517–520

    PubMed  CAS  Google Scholar 

  • Sixty Plus Reinfarction Study Group (1980) A double-blind trial to assess longterm anticoagulant therapy in elderly patients after myocardial infarction. Lancet II: 989–993

    Google Scholar 

  • Stevenson RE, Burton OM, Ferlanto GJ, Taylor HA (1980) Hazards of oral anticoagulants during pregnancy. J Am Med J 243: 1549–1551

    CAS  Google Scholar 

  • Temple R, Pledger GW (1980) The FDA’s critique of the Anturane Reinfarction Trial. N Engl J Med 303: 1488–1492

    Article  PubMed  CAS  Google Scholar 

  • The Persantine-Aspirin Reinfarction Study Group (1980) Pergantine and aspirin in coronary heart disease. Circulation G2: 449–461

    Google Scholar 

  • Theiss G, Vogler E, Wirtzfeld A, Keisel I, Blömer H (1980) Gerinnungsbefunde und rheologische Messungen bei Streptokinasebehandlung des akuten Myokardinfarktes. Klin Wochenschr 58: 607–615

    Article  PubMed  CAS  Google Scholar 

  • Überla K (1978) Multicenter two-year prospective study on the prevention of secondary myocardial infarction by ASA in comparison with phenprocumon and placebo. In: Breddin K, Dorndorf W, Loew D, Marx R (eds) Acetylsalicylic acid in cerebral ischemia and coronary heart disease. Schattauer, Stuttgart, pp 157–169

    Google Scholar 

  • Verstraete M (1971) Streptokinase in recent myocardial infarction. A controlled multicentre trial. Br Med J 3: 325–331

    Article  Google Scholar 

  • Veterans Administration Cooperative Clinical Trial (1973) J Am Med Ass 225: 724

    Article  Google Scholar 

  • Warlow C, Terry G, Kenmore ACF, Beattie AG, Douglas AG (1973) A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet 1: 934–936

    Article  Google Scholar 

  • Wray R, Maurer B, Shillingford J (1973) Prophylactic anticoagulant therapy in the prevention of calfvein thrombosis after myocardial infarction. N Engl J Med 288: 815–817

    Article  PubMed  CAS  Google Scholar 

  • Wright IG, Marple CD, Beck DF (1948) Report of the committee for the evaluation of anticoagulants in the treatment of coronary thrombosis with myocardial infarction. Am Heart J 36: 801–815

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. B. Ritter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Rehabilitationszentrum für Herz- und Kreislaufkranke Bad Krozingen, Südring 15, D-7812, Bad Krozingen, Germany

    Helmut Roskamm , P. Bubenheimer , C. Droste , A. Frey , L. Görnandt , H. Gohlke , Christa Gohlke-Bärwolf , P. Harnasch , K. Huesmann , D. Kalusche , W. Langosch , J. Petersen , B. Ritter , L. Samek , M. Schmuziger , K. Schnellbacher , P. Stürzenhofecker , A. Weisswange  & B. Wille , , , , , , , , , , , , , , , , ,  & 

  2. Lehrstuhl für Angewandte Physiologie der Universität, Hermann-Herder-Str. 7, D-7800, Freiburg, Germany

    E. Bassenge

  3. Medizinische Klinik I, Stadtkrankenhaus, Leimenstr. 20, D-6450, Hanau 1, Germany

    H.-J. Becker , W. A. Fach  & B. V. Mai ,  & 

  4. I. Medizinische Klinik B der Universität, Moorenstr. 5, D-4000, Düsseldorf, Germany

    G. Breithardt

  5. Abteilung Klinische Sozialmedizin, Klinikum der Universität, Bergheimerstr. 58, D-6900, Heidelberg 1, Germany

    L. Buchholz , W. Morgenstern , E. Nüssel  & R. Scheidt , ,  & 

  6. Strahlenklinik und Poliklinik, Abteilung für Radiologie mit Poliklinik, Universitätsklinikum Charlottenburg (FB 3), Spandauer Damm 130, D-1000, Berlin 19, Germany

    C. D. Claussen

  7. Abteilung Innere Medizin — Kardiologie, Universitätsklinikum Charlottenburg, Spandauer Damm 130, D-1000, Berlin 19, Germany

    H. Eichstädt

  8. Strahlenklinik und Poliklinik (WE 07), Abteilung Radiologie mit Poliklinik, Universitätsklinikum Charlottenburg, Spandauer Damm 130, D-1000, Berlin 19, Germany

    R. Felix  & D. Köhler  & 

  9. Kerckhoff-Klinik, Benekestr. 4-6, D-6350, Bad Nauheim, Germany

    M. Gottwik

  10. Emory University Hospital, Interventional Cardiovascular Medicine, Emory University School of Medicine, 1364 Clifton Road, 30322, N.E., Atlanta, Georgia, USA

    A. R. Gruentzig

  11. Cardiac Catheterization Laboratory, St. Louis University Medical Center, 1325 S. Grand Blvd., 63104, Mo., USA

    Th. Ischinger

  12. Zentrum der Inneren Medizin, Abteilung für Kardiologie, Klinikum der Universität, Theodor-Stern-Kai 7, D-6000, Frankfurt/Main 70, Germany

    M. Kaltenbach  & W. Schneider  & 

  13. Innere Abteilung der Kurklinik der LVA, D-6552, Bad Münster a. St. Ebernburg, Germany

    M. Keck

  14. Medizinische Poliklinik, Universität München, Pettenkoferstr. 8a, D-8000, München 2, Germany

    G. Lohmöller

  15. Innere Abteilung, Kreiskrankenhaus, Oßwaldstr. 1, D-8130, Starnberg, Germany

    H. Lydtin

  16. II. Medizinische Klinik, Abteilung Kardiologie, Universitäts-Krankenhaus Eppendorf, Martinistr. 52, D-2000, Hamburg 20, Germany

    D. G. Mathey

  17. Kardiologische Universitätsklinik, Allgemeines Krankenhaus der Stadt Wien, Garnisongasse 13, A-1097, Wien, Austria

    O. Pachinger  & H. Sochor  & 

  18. Pathologisches Institut, Städtische Krankenanstalten Mitte, Oelmühlenstr. 26, D-4800, Bielefeld 1, Germany

    R. Poche

  19. Röteweg 9, D-7800, Freiburg, Germany

    H. Reindell

  20. Max-Planck-Institut für Physiologische und Klinische Forschung, W.G. Kerckhoff-Institut, Parkstr. 1, D-6350, Bad Nauheim, Germany

    W. Schaper  & M. Siebes  & 

  21. I. Innere Abteilung, Krankenhaus Moabit, D-1000, Berlin 21, Germany

    K. P. Schüren

  22. Abteilung Innere Medizin III, Medizinische Klinik der Universität, Otfried-Müller-Straße, D-7400, Tübingen 1, Germany

    L. Seipel

  23. Departement Innere Medizin, Kantonsspital, Petersgraben 6, CH-4031, Basel, Switzerland

    E. Steinmann

  24. Pathologisches Institut, Städtische Krankenanstalten, Kulmbacher Str. 23, D-8580, Bayreuth, Germany

    M. Stolte

  25. Herz- und Gefäßchirurgische Abteilung, Rehabilitationszentrum für Herz- und Kreislaufkranke Bad Krozingen, Südring 15, D-7812, Bad Krozingen, Germany

    P. Tollenaere

  26. Internistisch-Kardiologische Abteilung, Theresienklinik, Brunnenallee 13, D-7812, Bad Krozingen, Germany

    H. Weidemann

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ritter, B. (1984). Antikoagulation, Aggregationshemmer, Fibrinolyse. In: Roskamm, H., et al. Koronarerkrankungen. Handbuch der inneren Medizin, vol 9 / 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69451-6_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-69451-6_35

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-69452-3

  • Online ISBN: 978-3-642-69451-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation